Femoroacetabular Impingement Syndrome
11
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femoroacetabular Impingement Syndrome
First-line Treatment for Femoroacetabular Impingement Syndrome
Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?
The Effect of Sacroiliac and Lumbar Mobilizations Applied in Addition to Conventional Physical Therapy
Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP)
In-Season Prevalence and Management of Hip and Groin Injuries in Competitive Athletes
Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure
Postoperative Hip Bracing After Hip Arthroscopy
Exercise Therapy for Femoroacetabular Impingement Syndrome
Early Versus Delayed Weightbearing in Femoroacetabular Impingement Syndrome Patients
Hip Arthroscopy Improves Muscle Volumes in Patients With Femoroacetabular Impingement Syndrome